Connect with us

Technology

Base Molecular Resonance™ Technologies Launches BMRT Security, Inc with $15 Million Investment Initiative Following U.S. IP Licensing Valuation of $1.8 Billion

Published

on

Revolutionary Quantum Physics Technology Poised to Redefine Public Safety

STUART, Fla., Feb. 26, 2025 /PRNewswire/ — Base Molecular Resonance™ Technologies (BMRT), the leading pioneer in quantum physics-driven security/medical/military solutions, today announced a $15 million investment initiative to accelerate the launch and deployment of BMRT Security, Inc. This follows BMRT Security, Inc.’s independently validated $1.8 billion U.S. IP licensing valuation, affirming the company’s leadership in next-generation security technology.

Breakthrough in Quantum Physics: Transforming Threat Detection

BMRT’s quantum physics innovation at the subatomic level has resulted in a groundbreaking patented technology capable of remotely detecting every element of the periodic table with unprecedented precision. This breakthrough, initially secured under a patent in November 2022, has since expanded with 18 additional patent assets in 2025.

BMRT’s Base Molecular Resonance™ (BMR™) technology identifies molecular resonance signatures of gunpowder, explosives, and illicit substances—both up close and at distance, non-intrusively, and with 100% accuracy. Unlike conventional security methods, BMRT’s quantum physics-based detection technology can identify threats through walls, vehicles, and solid barriers in real time.

This technology has been independently validated by a third-party study conducted by the Center for Applied Innovation at York St. John University in England. The landmark study confirmed BMRT’s 100% accuracy in detecting gunpowder, illegal drugs, and other threats in both blind and double-blind tests, with no false positives or false negatives.

“We are spearheading a security revolution,” asserted Robert “Bo” Short, Co-Founder & CEO of BMRT. “Our breakthrough quantum physics technology delivers unmatched precision in threat detection, arming law enforcement, government agencies, and private security firms with the ability to preemptively neutralize threats before they strike. This isn’t just innovation; it’s the future of security, where danger is stopped before it begins.”

Setting a New Global Standard for Security

BMR™ Technology is designed for instantaneous deployment across a wide range of environments, including:

Airports, public transit, maritime & border securitySchools, universities, and government buildingsStadiums, event venues, and critical infrastructurePrivate security, corporate headquarters, and executive protection

Ken Valentine, BMRT Board of Advisors Member and former Special Agent in Charge of the Dignitary Protective Division for the U.S. Secret Service, emphasized the importance of adoption:

“Having protected three U.S. Presidents, I know firsthand that traditional security methods have limitations. BMRT’s quantum physics technology eliminates the element of surprise for would-be attackers, giving law enforcement the power to intervene before a threat escalates.  BMR™ technology is a necessary tool for national security in an increasingly dangerous world.”

$1.8 Billion U.S. IP Licensing Valuation & Global Expansion Potential

BMRT’s $1.8 billion U.S. IP licensing valuation, conducted by an independent global firm, estimates an additional $3.5 billion in value through international expansion.

An Invitation to Visionary Investors

BMRT Security, Inc. invites forward-thinking investors to participate in this critical $15 million seed round as BMRT Security, Inc. prepares to disrupt the $400 billion global security market.

Lee Duke, Co-Founder & President of BMRT, stated:

“We are seeking investors committed to eliminating school shootings, stopping fentanyl from crossing our borders, and addressing threats wherever they arise. By harnessing the transformative power of quantum physics, we can revolutionize security systems and protect our schools and communities from these devastating dangers.”

About Base Molecular Resonance™ Technologies (BMRT)
BMRT has discovered a new area of Quantum Physics that utilizes resonant frequencies to detect particle interactions at subatomic levels. This technology, called Base Molecular Resonance™ (BMR™), can detect any compound or biological substance, including every element on the periodic table, and up to 200 cancers and other diseases. With over 20 years of prototyping and testing proving its unmatched detection capabilities, BMR™ has the potential to save millions of lives by pinpointing weapons, explosives, and other physical threats both up close and at great distances, and detecting cancers and other diseases long before they present clinical symptoms. The non-invasive, harmless, and instant scan has broad implications in cancer diagnostics, public safety, law enforcement, security, and military services.

For more information, visit www.BMRT.io 

Investment Inquiries
Robert “Bo “Short
Co-Founder & CEO
bo@BMRT.io

Media Contact
Bryan Adams
info@bmrt.io
800.522.4718 Ext. 1

Forward-Looking Statements
This press release contains forward-looking statements regarding anticipated market opportunities and growth potential. Actual results may vary based on external factors and industry developments.

View original content to download multimedia:https://www.prnewswire.com/news-releases/base-molecular-resonance-technologies-launches-bmrt-security-inc-with-15-million-investment-initiative-following-us-ip-licensing-valuation-of-1-8-billion-302386254.html

SOURCE Base Molecular Resonance Technologies, LLC

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

AiRISTA Launches Newest Version of Sofia™, Setting a Standard for Enterprise-Grade Real-Time Location Systems

Published

on

By

Platform modernization delivers unmatched flexibility, enterprise security, and open interoperability — reinforcing AiRISTA’s position as the RTLS platform built to scale with any technology environment

TIMONIUM, Md., July 21, 2026 /PRNewswire/ — AiRISTA, a leading provider of real-time location systems (RTLS) trusted by more than 300 organizations worldwide, today announced the newest release of its flagship Sofia™ real-time location intelligence platform. Building on the foundation established with the Vision RTLS platform, Sofia represents the next evolution of AiRISTA’s location intelligence platform to meet the evolving needs of enterprise and government customers.

As organizations increasingly rely on location intelligence to improve staff safety, operational efficiency, and workflow automation, Sofia enables them to leverage existing technology investments through an open, technology-agnostic platform rather than a single-vendor ecosystem.

Sy Sajjad, Founder and CEO, AiRISTA: “Sofia reflects what we’ve believed since founding AiRISTA: location intelligence should adapt to how an organization actually operates, not force the organization to adapt to a single vendor’s technology. With this release, we’ve strengthened the security, flexibility, and scalability that enterprise and healthcare customers require — while staying true to the open, technology-agnostic architecture that has always set Sofia apart.”

Key enhancements in the new release include:

A modernized user experience with simplified administration

Enterprise-grade security with Single Sign-On (SSO), Multi-Factor Authentication (MFA), TLS 1.3, and enhanced access controls

A centralized Integrations Hub supporting leading wireless infrastructure and enterprise applications, including EHR, MES, nurse call, and other operational systems

Multi-tenant tag roaming for seamless multi-site deployments

Enhanced dashboards, reporting, alert management, and platform performance

Unlike RTLS platforms built around a single positioning technology, Sofia supports Wi-Fi, Bluetooth® Low Energy (BLE), Ultra-Wideband (UWB), infrared (IR), GPS, and RFID within a single platform, allowing organizations to select the right technology for each use case without vendor lock-in. 

Jon Collins, Director of Integrated Product Solutions, AiRISTA: “The latest release of Sofia was built around a simple principle: the platform should improve outcomes, not add complexity. Whether that’s enabling a faster staff duress response, integrating location intelligence with electronic health records (EHRs), manufacturing execution systems (MES), nurse call, or other enterprise applications, or scaling seamlessly across multiple sites, this release removes friction at every layer—for administrators, IT teams, and the frontline staff who rely on Sofia every day. “

Organizations shouldn’t have to replace existing systems to unlock the value of location intelligence. Sofia was designed to integrate with the technologies customers already rely on. The latest release extends that flexibility with a new, centralized Integrations Hub supporting HPE Networking solutions (including HPE Aruba Networking and Juniper Mist), Cisco Spaces, Cisco Meraki, Cisco CMX, and other leading infrastructure platform.

Wyatt Meek, Chief Commercial Officer, AiRISTA: “What we hear consistently from customers evaluating RTLS is that they don’t want to choose between capability and flexibility — they want both. Sofia gives organizations enterprise-grade security and a modernized experience without asking them to give up the freedom to choose the right technology for each use case. That combination is difficult to find elsewhere in this market.”

Sofia is available now. Existing customers can work with their AiRISTA account team to plan upgrades. To learn more, visit www.airistaflow.com.

About AiRISTA

AiRISTA is a leading provider of real-time location systems (RTLS) and location intelligence solutions for healthcare, industrial, and government organizations. Trusted by more than 300 organizations worldwide, the Sofia platform delivers real-time visibility into people, assets, and environments while integrating with a broad ecosystem of wireless infrastructure and enterprise systems. AiRISTA is ISO 9001 and ISO 27001 certified.

View original content to download multimedia:https://www.prnewswire.com/news-releases/airista-launches-newest-version-of-sofia-setting-a-standard-for-enterprise-grade-real-time-location-systems-302830751.html

SOURCE AiRISTA Flow

Continue Reading

Technology

GCG Advisory Partners Reports Strong First-Half 2026, Marked by Four Strategic Acquisitions, $1.1 Billion in New Assets, and Completion of Three-Platform Model

Published

on

By

Firm expands AUM, welcomes new advisory teams, and deepens its national footprint following 2025 recapitalization

CHARLOTTE, N.C., July 21, 2026 /PRNewswire/ — GCG Advisory Partners (“GCG”), a national wealth management aggregator platform, today announced a series of milestones completed in the first half of 2026 that reinforce the firm’s growth trajectory and its position as a partner of choice for independent financial advisors.

Since its August 2025 recapitalization with BharCap Partners, GCG has grown EBITDA by more than 200%, a pace that reflects both a disciplined deal strategy and the caliber of the teams choosing to join. The firm acquires and supports registered investment advisory (RIA) practices nationwide, giving each the infrastructure, capital, and flexibility to keep growing while staying focused on clients.

Completion of the Three-Platform Model

GCG also completed the build-out of its three-platform operating model (independent RIA, broker-dealer/corporate RIA, and hybrid RIA), so advisors can choose the affiliation that best fits their practice and clients. Every prospective partner now has a clear route in, whatever structure they prefer.

Four Acquisitions, Four New Chapters

Gunderson Capital Management. Closed April 3, 2026, this deal added roughly $578 million in AUM, custodied at Charles Schwab, and established GCG’s independent RIA channel. The Mount Pleasant, S.C. firm is led by nationally recognized market commentator Bill Gunderson.

Gateway Capital Advisors. Also effective that day, this $300 million-plus practice joined through an asset purchase, recognized for its entrepreneurial, organically driven growth and deep client-planning work.

Head Investment Partners. In June, this $180 million Knoxville practice joined GCG, led by 30-year advisor Daniel Head and known for its options and risk-management expertise, giving GCG its first footprint in Tennessee.

BlueChip Financial Advisors. A hybrid RIA custodying through Fidelity Institutional Wealth Services, it opened GCG’s first presence in the Northeast and rounded out the firm’s affiliation options, giving incoming teams the full range of ways to join.

Each brings specialized capabilities to GCG’s expanding roster of practices.

Leadership Perspective

“The first half of 2026 has been about disciplined execution: completing our platform, welcoming exceptional advisory teams, and building a firm that advisors and institutional partners alike can trust. We’re proud of what our team has accomplished, and we remain focused on sustainable, high-quality growth, driven by both organic momentum and disciplined acquisitions, through the back half of the year and into 2027.”

— Joel Burris, CEO & Managing Partner, GCG Advisory Partners

Looking Ahead

GCG continues to evaluate new opportunities and remains committed to supporting advisors and clients across all three affiliation models. The firm expects to share further updates later in 2026.

For entrepreneurial advisors looking to build lasting equity in their practice, GCG offers the capital, infrastructure, and partnership to make it happen. To start a confidential conversation, contact our team.

About GCG Advisory Partners

GCG Advisory Partners is a national wealth management aggregator that acquires and supports registered investment advisory practices nationwide. Through its independent RIA, broker-dealer/corporate RIA, and hybrid RIA channels, the firm gives advisors the infrastructure, resources, and flexibility to grow while staying focused on their clients. GCG is backed by BharCap Partners. For more information, visit www.gcgap.com.

Media Contact:

Nicole Caputo
Contact@gcgap.com
704-372-4491

View original content to download multimedia:https://www.prnewswire.com/news-releases/gcg-advisory-partners-reports-strong-first-half-2026–marked-by-four-strategic-acquisitions-1-1-billion-in-new-assets-and-completion-of-three-platform-model-302830173.html

SOURCE GCG Advisory Partners

Continue Reading

Technology

Buzz Health and VetHubRx Partner to Bring Real-Time Prescription Savings to Veterinary Care

Published

on

By

Strategic integration embeds multi-card discount pricing directly into veterinary e-prescribing workflows, expanding affordability and price transparency for pet owners at the pharmacy counter

FORT WALTON BEACH, Fla., July 21, 2026 /PRNewswire/ — Buzz Health™, a healthcare technology company, and VetHubRx, a veterinary e-prescribing platform, today announced a strategic partnership to integrate real-time prescription discount pricing directly into VetHubRx’s e-prescribing and consumer-facing platforms.

Through the collaboration, VetHubRx will embed Buzz Health’s RxCompare® pricing infrastructure into its prescribing workflow, enabling veterinary providers and pet owners to access and apply the lowest available discount price at the point of prescribing and fulfillment. The integration supports automated best-price routing via Buzz Health’s SmartBIN® across a configurable multi-card discount network, delivering real-time price visibility within the digital prescribing experience and seamless claims adjudication through RxCompare’s pharmacy network and infrastructure.

The partnership marks Buzz Health’s first integration with a veterinary e-prescribing platform, extending the company’s prescription affordability technology into a market where most medication purchases are paid entirely out of pocket, given that only 4 to 5% of pets in the U.S. are insured, according to the North American Pet Health Insurance Association.

Unlike human healthcare, pet insurance rarely covers prescription drugs at the point of sale, leaving pet owners fully exposed to retail pricing with limited visibility into available savings. Many pet owners are unaware that the same prescription discount programs available for human medications can also be applied to their pet’s prescriptions, a gap this partnership addresses by embedding savings directly into the prescribing workflow.

“Veterinary prescribing is undergoing a digital transformation, and this partnership positions Buzz Health at the forefront of that shift,” said Lathe Bigler, Senior Vice President, Business Strategy at Buzz Health. “By embedding real-time pricing and multi-card savings directly into the prescribing workflow, we are helping veterinary providers deliver price transparency to pet owners before they arrive at the pharmacy, reducing surprises at the counter and improving prescription fulfillment rates.”

VetHubRx is a standalone e-prescribing application designed for veterinary clinics and animal hospitals, enabling providers to generate and transmit prescriptions electronically to retail pharmacies nationwide. Animal hospitals typically do not dispense medications on-site, meaning prescriptions are mostly routed to retail pharmacies, making real-time pricing visibility at the pharmacy counter particularly valuable. The platform also includes a consumer-facing app that engages pet owners on refills and prescription management.

“Our providers want to give pet owners every advantage when it comes to affording the medications their animals need,” said MJ Hamilton, CEO and Founder of VetHubRx. “Integrating real-time discount pricing into our workflow means pet owners can see the most affordable option at the pharmacy closest to them, all within the same digital experience their veterinarian uses to prescribe. It removes friction from the process and helps ensure prescriptions are filled.”

The partnership focuses on prescriptions for human-equivalent medications commonly prescribed for pets, which are filled at retail pharmacies across the country. The integration applies SmartBIN technology to automatically route each prescription to the discount card offering the lowest available price using a single set of processing codes, ensuring pet owners receive optimal savings with no additional steps required by the prescriber or pharmacist.

Buzz Health currently supports prescription access across thousands of pharmacies nationwide and continues expanding its platform to serve e-prescribing applications, EMR/EHR integrations, and additional enterprise partners.

About Buzz Health

Buzz Health is a healthcare technology company delivering intelligent, customizable prescription solutions through its integrated platforms, including BuzzRx, RxCompare, and RxAffect. Designed for scale and flexibility, Buzz Health’s technology helps streamline pharmacy operations, optimize claims in real time, and improve access and affordability across the prescription ecosystem. By serving as the intelligence layer behind prescription savings and benefit navigation, Buzz Health enables measurable cost reductions, improved adherence, and better health outcomes. Learn more at www.buzzhealth.com.

About VetHubRx

VetHubRx is the first and only e-prescribing platform built exclusively for veterinarians, empowering clinics to electronically prescribe to virtually any participating pharmacy nationwide. By eliminating phone calls, faxes, and unnecessary administrative work, VetHubRx streamlines the prescribing process for veterinary teams while giving pet owners the freedom to fill prescriptions at the pharmacy that best meets their needs. Faster prescribing, greater convenience, and improved access to medications help create a better experience for both clinics and pet owners. Learn more at vethubrx.com.

Media Contact
buzzhealthPR@supremecomms.ai

View original content to download multimedia:https://www.prnewswire.com/news-releases/buzz-health-and-vethubrx-partner-to-bring-real-time-prescription-savings-to-veterinary-care-302828773.html

SOURCE Buzz Health

Continue Reading

Trending